Molecular and nonmolecular diagnostic methods for invasive fungal infections

Clinical Microbiology Reviews

Volumn 27, Issue 3, 2014, Pages 490-526

  Arvanitis, Marios ^a   Anagnostou, Theodora ^a   Fuchs, Beth Burgwyn ^a   Caliendo, Angela M ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; GEL ELECTROPHORESIS; HISTOPATHOLOGY; HUMAN; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DIAGNOSTICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SYSTEMIC MYCOSIS; ANIMAL; FUNGUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSES; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS;

ANIMALS; FUNGI; HUMANS; MICROBIOLOGICAL TECHNIQUES; MYCOSES; REPRODUCIBILITY OF RESULTS;

EID: 84903600596     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00091-13     Document Type: Article

References (296)

1. Chen Y, Wang H, Kantarjian H, Cortes J. 2013. Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leuk. Lymphoma 54:1411-1417. http://dx.doi.org/10.3109 /10428194.2012.745525.
2. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM. 2010. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin. Infect. Dis. 50:1101-1111. http://dx.doi.org/10.1086/651262.
3. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci. Transl. Med. 4:165rv113. http://dx.doi.org/10.1126/scitranslmed.3004404.
4. Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ. 2012. Performance of Candida real-time polymerase chain reaction, beta-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin. Infect. Dis. 54:1240-1248. http://dx.doi.org /10.1093/cid/cis200.
5. Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG. 2010. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin. Infect. Dis. 50:1559-1567. http://dx.doi.org/10.1086/652768.
6. Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP. 2011. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg. Infect. Dis. 17:1855-1864. http://dx.doi.org/10.3201/eid1710.110087.
7. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer, Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14. http://dx.doi.org/10.1086/323335.
8. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821. http: //dx.doi.org/10.1086/588660.
9. Reinwald M, Buchheidt D, Hummel M, Duerken M, Bertz H, Schwerdtfeger R, Reuter S, Kiehl MG, Barreto-Miranda M, Hofmann WK, Spiess B. 2013. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One 8:e56706. http://dx.doi.org/10.1371/journal.pone.0056706.
10. Springer J, Loeffler J, Heinz W, Schlossnagel H, Lehmann M, Morton O, Rogers TR, Schmitt C, Frosch M, Einsele H, Kurzai O. 2011. Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients. J. Clin. Microbiol. 49:1267-1273. http://dx.doi.org/10.1128/JCM.01679-10.
11. Guarner J, Brandt ME. 2011. Histopathologic diagnosis of fungal infections in the 21st century. Clin. Microbiol. Rev. 24:247-280. http://dx.doi.org/10.1128/CMR.00053-10.
12. Moran C, Grussemeyer CA, Spalding JR, Benjamin DK, Jr, Reed SD. 2010. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am. J. Infect. Control 38:78-80. http://dx.doi.org/10.1016/j.ajic.2009.06.014.
13. Morrell M, Fraser VJ, Kollef MH. 2005. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49:3640-3645. http://dx.doi.org/10.1128/AAC.49.9.3640-3645.2005.
14. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31. http://dx.doi.org/10.1086/504810.
15. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, Shorr AF. 2010. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect. Dis. 10:150. http://dx.doi.org/10.1186/1471-2334-10-150.
16. Arnold HM, Micek ST, Shorr AF, Zilberberg MD, Labelle AJ, Kothari S, Kollef MH. 2010. Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy 30:361-368. http://dx.doi.org/10.1592/phco.30.4.361.
17. Chamilos G, Lewis RE, Kontoyiannis DP. 2008. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin. Infect. Dis. 47:503-509. http://dx.doi.org/10.1086/590004.
18. Ericson EL, Klingspor L, Ullberg M, Ozenci V. 2012. Clinical comparison of the Bactec Mycosis IC/F, BacT/Alert FA, and BacT/AlertFNblood culture vials for the detection of candidemia. Diagn. Microbiol. Infect. Dis. 73:153-156. http://dx.doi.org/10.1016/j.diagmicrobio.2012.02.020.
19. Park BR, Kim TH, Kim HR, Lee MK. 2011. Comparative analysis of simulated candidemia using two different blood culture systems and the rapid identification of Candida albicans. Ann. Clin. Lab. Sci. 41:251-256.
20. Kosmin AR, Fekete T. 2008. Use of fungal blood cultures in an academic medical center. J. Clin. Microbiol. 46:3800-3801. http://dx.doi.org/10.1128/JCM.00796-08.
21. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A. 2001. Elevation of blood (1→3)-beta-D-glucan concentrations in hemodialysis patients. Nephron 89:15-19. http://dx.doi.org/10.1159/000046037.
22. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH. 2005. Multicenter clinical evaluation of the (1→3) beta-Dglucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41:654-659. http://dx.doi.org/10.1086/432470.
23. Nett J, Lincoln L, Marchillo K, Andes D. 2007. Beta-1,3 glucan as a test for central venous catheter biofilm infection. J. Infect. Dis. 195:1705-1712. http://dx.doi.org/10.1086/517522.
24. Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J. 2010. Difficulties in using 1,3-β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis. J. Med. Microbiol. 59:1016-1022. http: //dx.doi.org/10.1099/jmm.0.019299-0.
25. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. 2009. Diagnostic performance of the (1→3)-beta-D-glucan assay for invasive fungal disease. Clin. Infect. Dis. 49:1650-1659. http://dx.doi.org/10.1086/647942.
26. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. 2009. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J. Clin. Microbiol. 47:129-133. http://dx.doi.org/10.1128/JCM.00506-08.
27. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O, Third European Conference on Infections in Leukemia. 2012. Beta-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin. Infect. Dis. 54:633-643. http://dx.doi.org/10.1093/cid/cir897.
28. Moragues MD, Ortiz N, Iruretagoyena JR, Garcia-Ruiz JC, Amutio E, Rojas A, Mendoza J, Quindos G, Ponton-San Emeterio J. 2004. Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm. Infecc. Microbiol. Clin. 22:83-88. http://dx.doi.org/10.1016/S0213-005X(04)73039-6.
29. Ponton J, Jones JM. 1986. Identification of two germ-tube-specific cell wall antigens of Candida albicans. Infect. Immun. 54:864-868.
30. Ponton J, Quindos G, Arilla MC, Mackenzie DW. 1994. Simplified adsorption method for detection of antibodies to Candida albicans germ tubes. J. Clin. Microbiol. 32:217-219.
31. Quindos G, Ponton J, Cisterna R. 1987. Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis. Eur. J. Clin. Microbiol. 6:142-146. http://dx.doi.org/10.1007/BF02018195.
32. Garcia-Ruiz JC, del Carmen Arilla M, Regulez P, Quindos G, Alvarez A, Ponton J. 1997. Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies. J. Clin. Microbiol. 35:3284-3287.
33. Zaragoza R, Peman J, Quindos G, Iruretagoyena JR, Cuetara MS, Ramirez P, Gomez MD, Camarena JJ, Viudes A, Ponton J, Candida albicans Germ Tube Antibody Detection in Critically Ill Patients. 2009. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin. Microbiol. Infect. 15:592-595. http://dx.doi.org/10.1111/j.1469-0691.2009.02794.x.
34. Peman J, Zaragoza R, Quindos G, Alkorta M, Cuetara MS, Camarena JJ, Ramirez P, Gimenez MJ, Martin-Mazuelos E, Linares-Sicilia MJ, Ponton J, Candida albicans Germ Tube Antibody Detection in Critically Ill Patients. 2011. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect. Dis. 11:60. http://dx.doi.org/10.1186/1471-2334-11-60.
35. Leon C, Ruiz-Santana S, Saavedra P, Castro C, Ubeda A, Loza A, Martin-Mazuelos E, Blanco A, Jerez V, Ballus J, Alvarez-Rocha L, Utande-Vazquez A, Farinas O. 2012. Value of beta-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med. 38:1315-1325. http://dx.doi.org/10.1007/s00134-012-2616-y.
36. Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. 2009. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J. Med. Microbiol. 58:606-615. http://dx.doi.org/10.1099/jmm.0.006452-0.
37. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 48:265-273. http: //dx.doi.org/10.1086/595846.
38. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 50:1091-1100. http://dx.doi.org/10.1086/651263.
39. Tarrand JJ, Han XY, Kontoyiannis DP, May GS. 2005. Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J. Clin. Microbiol. 43:382-386. http://dx.doi.org/10.1128/JCM.43.1.382-386.2005.
40. Horvath JA, Dummer S. 1996. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am. J. Med. 100:171-178. http://dx.doi.org/10.1016/S0002-9343(97)89455-7.
41. Zmeili OS, Soubani AO. 2007. Pulmonary aspergillosis: a clinical update. QJM 100:317-334. http://dx.doi.org/10.1093/qjmed/hcm035.
42. Tashiro T, Izumikawa K, Tashiro M, Takazono T, Morinaga Y, Yamamoto K, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Kohno S. 2011. Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med. Mycol. 49:581-587. http://dx.doi.org/10.3109/13693786.2010.548084.
43. Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J, Soubani AO. 2006. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J. Crit. Care 21:322-327. http://dx.doi.org/10.1016/j.jcrc.2006.03.006.
44. Simoneau E, Kelly M, Labbe AC, Roy J, Laverdiere M. 2005. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant. 35:303-306. http://dx.doi.org/10.1038/sj.bmt.1704793.
45. Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller T. 2009. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J. Clin. Microbiol. 47:3138-3141. http://dx.doi.org/10.1128 /JCM.01070-09.
46. Bariola JR, Perry P, Pappas PG, Proia L, Shealey W, Wright PW, Sizemore JM, Robinson M, Bradsher RW, Jr. 2010. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin. Infect. Dis. 50:797-804. http://dx.doi.org /10.1086/650579.
47. Lemos LB, Guo M, Baliga M. 2000. Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann. Diagn. Pathol. 4:391-406. http://dx.doi.org/10.1053/adpa.2000.20755.
48. Patel AJ, Gattuso P, Reddy VB. 2010. Diagnosis of blastomycosis in surgical pathology and cytopathology: correlation with microbiologic culture. Am. J. Surg. Pathol. 34:256-261. http://dx.doi.org/10.1097/PAS.0b013e3181ca48a5.
49. Gazzoni AF, Severo CB, Salles EF, Severo LC. 2009. Histopathology, serology and cultures in the diagnosis of cryptococcosis. Rev. Inst. Med. Trop. Sao Paulo 51:255-259. http://dx.doi.org/10.1590/S0036-46652009000500004.
50. Saubolle MA. 2007. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann. N. Y. Acad. Sci. 1111:301-314. http://dx.doi.org/10.1196 /annals.1406.049.
51. Pickering JW, Sant HW, Bowles CAP, Roberts WL, Woods GL. 2005. Evaluation of a (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43:5957-5962. http://dx.doi.org/10.1128/JCM.43.12.5957-5962.2005.
52. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S. 2004. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J. Clin. Microbiol. 42:2733-2741. http://dx.doi.org /10.1128/JCM.42.6.2733-2741.2004.
53. Obayashi T, Negishi K, Suzuki T, Funata N. 2008. Reappraisal of the serum (1→3)-beta-D-glucan assay for the diagnosis of invasive fungal infections-a study based on autopsy cases from 6 years. Clin. Infect. Dis. 46:1864-1870. http://dx.doi.org/10.1086/588295.
54. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205. http://dx.doi.org/10.1086/421944.
55. Marty FM, Koo S. 2009. Role of (1→3)-beta-D-glucan in the diagnosis of invasive aspergillosis. Med. Mycol. 47(Suppl 1):S233-S240. http://dx.doi.org/10.1080/13693780802308454.
56. Mennink-Kersten MA, Ruegebrink D, Verweij PE. 2008. Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity. Clin. Infect. Dis. 46:1930-1931. http://dx.doi.org/10.1086/588563.
57. Mennink-Kersten MA, Verweij PE. 2006. Non-culture-based diagnostics for opportunistic fungi. Infect. Dis. Clin. North Am. 20:711-727. http://dx.doi.org/10.1016/j.idc.2006.06.009.
58. Martins LM, de Andrade HM, Vainstein MH, Wanke B, Schrank A, Balaguez CB, dos Santos PR, Santi L, Pires Sda F, da Silva AS, de Castro JA, Brandao RM, do Monte SJ. 2013. Immunoproteomics and immunoinformatics analysis of Cryptococcus gattii: novel candidate antigens for diagnosis. Future Microbiol. 8:549-563. http://dx.doi.org/10.2217/fmb.13.22.
59. Metan G, Koc AN, Atalay A, Kaynar LG, Ozturk A, Alp E, Eser B. 2012. What should be the optimal cut-off of serum 1,3-beta-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies? Scand. J. Infect. Dis. 44:330-336. http://dx.doi.org/10.3109/00365548.2011.638319.
60. Tortorano AM, Esposto MC, Prigitano A, Grancini A, Ossi C, Cavanna C, Cascio GL. 2012. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J. Clin. Microbiol. 50:1051-1053. http://dx.doi.org/10.1128/JCM.05946-11.
61. Wheat LJ, Hackett E, Durkin M, Connolly P, Petraitiene R, Walsh TJ, Knox K, Hage C. 2007. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin. Vaccine Immunol. 14:638-640. http://dx.doi.org/10.1128/CVI.00479-06.
62. Maschmeyer G, Calandra T, Singh N, Wiley J, Perfect J. 2009. Invasive mould infections: a multi-disciplinary update. Med. Mycol. 47:571-583. http://dx.doi.org/10.1080/13693780902946559.
63. Klont RR, Mennink-Kersten MA, Ruegebrink D, Rijs AJ, Blijlevens NM, Donnelly JP, Verweij PE. 2006. Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis. Clin. Infect. Dis. 43:e23-e25. http://dx.doi.org /10.1086/505603.
64. Mennink-Kersten MA, Donnelly JP, Verweij PE. 2004. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4:349-357. http://dx.doi.org/10.1016 /S1473-3099(04)01045-X.
65. Marr KA, Laverdiere M, Gugel A, Leisenring W. 2005. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40:1762-1769. http://dx.doi.org/10.1086/429921.
66. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. 2004. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J. Infect. Dis. 190:641-649. http://dx.doi.org/10.1086/422009.
67. Berenguer J, Allende MC, Lee JW, Garrett K, Lyman C, Ali NM, Bacher J, Pizzo PA, Walsh TJ. 1995. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am. J. Respir. Crit. Care Med. 152:1079-1086.
68. Zou M, Tang L, Zhao S, Zhao Z, Chen L, Chen P, Huang Z, Li J, Chen L, Fan X. 2012. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One 7:e43347. http://dx.doi.org/10.1371/journal.pone.0043347.
69. Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM. 2013. The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis. Clin. Infect. Dis. 57:1001-1004. http://dx.doi.org/10.1093/cid/cit393.
70. Mikulska M, Raiola AM, Signori A, Furfaro E, Del Bono V, Bacigalupo A, Viscoli C. 2013. Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis. Clin. Infect. Dis. 57:1786-1787. http://dx.doi.org/10.1093/cid/cit565.
71. Husain S, Clancy CJ, Nguyen MH, Swartzentruber S, Leather H, LeMonte AM, Durkin MM, Knox KS, Hage CA, Bentsen C, Singh N, Wingard JR, Wheat LJ. 2008. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin. Vaccine Immunol. 15:1760-1763. http://dx.doi.org/10.1128/CVI.00226-08.
72. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. 2004. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42:5517-5522. http://dx.doi.org/10.1128/JCM.42.12.5517-5522.2004.
73. Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, Meers S, Verbeken E, Verhoef G, Van Eldere J, Lagrou K. 2009. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49:1688-1693. http://dx.doi.org/10.1086/647935.
74. D'Haese J, Theunissen K, Vermeulen E, Schoemans H, De Vlieger G, Lammertijn L, Meersseman P, Meersseman W, Lagrou K, Maertens J. 2012. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J. Clin. Microbiol. 50:1258-1263. http://dx.doi.org/10.1128/JCM.06423-11.
75. Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV. 2004. Prospective clinical evaluation of lower cutoffs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br. J. Haematol. 126: 852-860. http://dx.doi.org/10.1111/j.1365-2141.2004.05140.x.
76. Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, Heinen C, Crepin B, Van Eldere J, Tabouret M, Donnelly JP, Verweij PE. 2007. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin. Infect. Dis. 44:1329-1336. http://dx.doi.org/10.1086/514349.
77. Sampsonas F, Kontoyiannis DP, Dickey BF, Evans SE. 2011. Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study. Cancer 117:3424-3433. http://dx.doi.org/10.1002/cncr.25905.
78. White PL, Parr C, Thornton C, Barnes RA. 2013. Evaluation of realtime PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 51:1510-1516. http://dx.doi.org/10.1128 /JCM.03189-12.
79. Thornton CR. 2008. Development of an immunochromatographic lateralflow device for rapid serodiagnosis of invasive aspergillosis. Clin. Vaccine Immunol. 15:1095-1105. http://dx.doi.org/10.1128/CVI.00068-08.
80. Thornton C, Johnson G, Agrawal S. 2012. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J. Vis. Exp. 22:3721. http://dx.doi.org/10.3791/3721.
81. Wiederhold NP, Thornton CR, Najvar LK, Kirkpatrick WR, Bocanegra R, Patterson TF. 2009. Comparison of lateral flow technology and galactomannan and (1→3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin. Vaccine Immunol. 16:1844-1846. http://dx.doi.org/10.1128/CVI.00268-09.
82. Held J, Schmidt T, Thornton CR, Kotter E, Bertz H. 2013. Comparison of a novel Aspergillus lateral-flow device and the Platelia(R) galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection 41:1163-1169. http://dx.doi.org/10.1007/s15010-013-0472-5.
83. de Heer K, van der Schee MP, Zwinderman K, van den Berk IA, Visser CE, van Oers R, Sterk PJ. 2013. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study. J. Clin. Microbiol. 51:1490-1495. http://dx.doi.org/10.1128/JCM.02838-12.
84. Syhre M, Scotter JM, Chambers ST. 2008. Investigation into the production of 2-pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med. Mycol. 46:209-215. http://dx.doi.org/10.1080/13693780701753800.
85. Chambers ST, Syhre M, Murdoch DR, McCartin F, Epton MJ. 2009. Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. Med. Mycol. 47:468-476. http://dx.doi.org/10.1080 /13693780802475212.
86. Harris JR, Marston BJ, Sangrujee N, DuPlessis D, Park B. 2011. Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP). PLoS One 6:e23158. http://dx.doi.org/10.1371/journal.pone.0023158.
87. LaRocque RC, Katz JT, Perruzzi P, Baden LR. 2003. The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus. Clin. Infect. Dis. 37:1380-1383. http://dx.doi.org/10.1086/379071.
88. Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura K, Kumagai S. 2012. Diagnostic accuracy of serum 1,3-beta-D-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and metaanalysis. J. Clin. Microbiol. 50:7-15. http://dx.doi.org/10.1128/JCM.05267-11.
89. Karageorgopoulos DE, Qu JM, Korbila IP, Zhu YG, Vasileiou VA, Falagas ME. 2013. Accuracy of beta-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin. Microbiol. Infect. 19:39-49. http://dx.doi.org/10.1111/j.1469-0691.2011.03760.x.
90. Costa JM, Botterel F, Cabaret O, Foulet F, Cordonnier C, Bretagne S. 2012. Association between circulating DNA, serum (1→3)-beta-Dglucan, and pulmonary fungal burden in Pneumocystis pneumonia. Clin. Infect. Dis. 55:e5-e8. http://dx.doi.org/10.1093/cid/cis412.
91. Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, Nagao M, Takakura S, Ichiyama S. 2012. Quantitative real-time PCR and the (1→3)-beta-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin. Microbiol. Infect. 18: 591-597. http://dx.doi.org/10.1111/j.1469-0691.2011.03605.x.
92. Koo S, Baden LR, Marty FM. 2012. Post-diagnostic kinetics of the (1→3)-beta-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia. Clin. Microbiol. Infect. 18: E122-E127. http://dx.doi.org/10.1111/j.1469-0691.2012.03777.x.
93. D'Souza CA, Kronstad JW, Taylor G, Warren R, Yuen M, Hu G, Jung WH, Sham A, Kidd SE, Tangen K, Lee N, Zeilmaker T, Sawkins J, McVicker G, Shah S, Gnerre S, Griggs A, Zeng Q, Bartlett K, Li W, Wang X, Heitman J, Stajich JE, Fraser JA, Meyer W, Carter D, Schein J, Krzywinski M, Kwon-Chung KJ, Varma A, Wang J, Brunham R, Fyfe M, Ouellette BF, Siddiqui A, Marra M, Jones S, Holt R, Birren BW, Galagan JE, Cuomo CA. 2011. Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. mBio 2:e00342-10. http://dx.doi.org/10.1128/mBio.00342-10.
94. Dominic RS, Prashanth H, Shenoy S, Baliga S. 2009. Diagnostic value of latex agglutination in cryptococcal meningitis. J. Lab. Physicians 1:67-68. http://dx.doi.org/10.4103/0974-2727.59702.
95. Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S, European Conference on Infections in Leukemia Laboratory Working Group. 2012. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant. 47:846-854. http://dx.doi.org/10.1038/bmt.2011.178.
96. Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O, ESCMID EFISG Study Group and ECMM. 2014. ESCMID/ ECMMjoint clinical guideline for the diagnosis and management of rare invasive yeast infections. Clin. Microbiol. Infect. 20(Suppl 3):76-98. http://dx.doi.org/10.1111/1469-0691.12360.
97. McMullan BJ, Halliday C, Sorrell TC, Judd D, Sleiman S, Marriott D, Olma T, Chen SC. 2012. Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS One 7:e49541. http://dx.doi.org/10.1371/journal.pone.0049541.
98. Lawn SD, Wood R. 2012. Point-of-care urine antigen screening tests for tuberculosis and cryptococcosis: potential for mortality reduction in antiretroviral treatment programs in Africa. Clin. Infect. Dis. 54:739-740. http://dx.doi.org/10.1093/cid/cir908.
99. Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A, Kamya MR, Bohjanen PR, Boulware DR. 2010. Costeffectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/ microL who start HIV therapy in resource-limited settings. Clin. Infect. Dis. 51:448-455. http://dx.doi.org/10.1086/655143.
100. Hage CA, Ribes JA, Wengenack NL, Baddour LM, Assi M, McKinsey DS, Hammoud K, Alapat D, Babady NE, Parker M, Fuller D, Noor A, Davis TE, Rodgers M, Connolly PA, El Haddad B, Wheat LJ. 2011. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin. Infect. Dis. 53:448-454. http://dx.doi.org/10.1093/cid/cir435.
101. Saccente M, Woods GL. 2010. Clinical and laboratory update on blastomycosis. Clin. Microbiol. Rev. 23:367-381. http://dx.doi.org/10.1128 /CMR.00056-09.
102. Hage CA, Kirsch EJ, Stump TE, Kauffman CA, Goldman M, Connolly P, Johnson PC, Wheat LJ, Baddley JW. 2011. Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay. Clin. Vaccine Immunol. 18:661-666. http://dx.doi.org/10.1128/CVI.00389-10.
103. Assi M, Martin S, Wheat LJ, Hage C, Freifeld A, Avery R, Baddley JW, Vergidis P, Miller R, Andes D, Young JA, Hammoud K, Huprikar S, McKinsey D, Myint T, Garcia-Diaz J, Esguerra E, Kwak EJ, Morris M, Mullane KM, Prakash V, Burdette SD, Sandid M, Dickter J, Ostrander D, Antoun SA, Kaul DR. 2013. Histoplasmosis after solid organ transplant. Clin. Infect. Dis. 57:1542-1549. http://dx.doi.org/10.1093/cid /cit593.
104. Hage CA, Wheat LJ. 2010. Diagnosis of pulmonary histoplasmosis using antigen detection in the bronchoalveolar lavage. Expert Rev. Respir. Med. 4:427-429. http://dx.doi.org/10.1586/ers.10.36.
105. Richer SM, Smedema ML, Durkin MM, Brandhorst TT, Hage CA, Connolly PA, Leland DS, Davis TE, Klein BS, Wheat LJ. 2014. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin. Vaccine Immunol. 21:143-146. http://dx.doi.org/10.1128/CVI.00597-13.
106. Ampel NM. 2010. The diagnosis of coccidioidomycosis. F1000 Med. Rep. 2:2. http://dx.doi.org/10.3410/M2-2.
107. Blair JE, Mendoza N, Force S, Chang YH, Grys TE. 2013. Clinical specificity of the enzyme immunoassay test for coccidioidomycosis varies according to the reason for its performance. Clin. Vaccine Immunol. 20:95-98. http://dx.doi.org/10.1128/CVI.00531-12.
108. Thompson GR, 3rd, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA. 2012. Serum (1→3)-beta-D-glucan measurement in coccidioidomycosis. J. Clin. Microbiol. 50:3060-3062. http://dx.doi.org /10.1128/JCM.00631-12.
109. Millon L, Larosa F, Lepiller Q, Legrand F, Rocchi S, Daguindau E, Scherer E, Bellanger AP, Leroy J, Grenouillet F. 2013. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin. Infect. Dis. 56:e95-e101. http://dx.doi.org/10.1093/cid/cit094.
110. Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, Etienne K, Deak E, Derado G, Shieh WJ, Drew C, Zaki S, Sugerman D, Gade L, Thompson EH, Sutton DA, Engelthaler DM, Schupp JM, Brandt ME, Harris JR, Lockhart SR, Turabelidze G, Park BJ. 2012. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N. Engl. J. Med. 367:2214-2225. http://dx.doi.org/10.1056/NEJMoa1204781.
111. Boutati EI, Anaissie EJ. 1997. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 90:999-1008.
112. Lionakis MS, Kontoyiannis DP. 2004. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer 100:165-172. http://dx.doi.org/10.1002/cncr.11876.
113. Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. 2004. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin. Microbiol. Infect. 10:922-925. http://dx.doi.org/10.1111/j.1469-0691.2004.00933.x.
114. Norkin M, Wingard JR. 2013. Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients. J. Natl. Compr. Canc. Netw. 11:941-949.
115. Strick LB, Wald A. 2006. Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol. Diagn. Ther. 10:17-28. http://dx.doi.org/10.1007/BF03256439.
116. Ruchel R. 1993. Diagnosis of invasive mycoses in severely immunosuppressed patients. Ann. Hematol. 67:1-11. http://dx.doi.org/10.1007 /BF01709659.
117. Stevens DA. 2002. Diagnosis of fungal infections: current status. J. Antimicrob. Chemother. 49(Suppl 1):11-19. http://dx.doi.org/10.1093/jac /49.suppl_1.11.
118. Maaroufi Y, Heymans C, De Bruyne JM, Duchateau V, Rodriguez-Villalobos H, Aoun M, Crokaert F. 2003. Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay. J. Clin. Microbiol. 41:3293-3298. http://dx.doi.org/10.1128/JCM.41.7.3293-3298.2003.
119. Muller FM, Werner KE, Kasai M, Francesconi A, Chanock SJ, Walsh TJ. 1998. Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruption. J. Clin. Microbiol. 36:1625-1629.
120. Gonzalez-Mendoza D, Argumedo-Delira R, Morales-Trejo A, Pulido-Herrera A, Cervantes-Diaz L, Grimaldo-Juarez O, Alarcon A. 2010. A rapid method for isolation of total DNA from pathogenic filamentous plant fungi. Genet. Mol. Res. 9:162-166. http://dx.doi.org/10.4238/vol9-1gmr680.
121. Francesconi A, Kasai M, Harrington SM, Beveridge MG, Petraitiene R, Petraitis V, Schaufele RL, Walsh TJ. 2008. Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR. J. Clin. Microbiol. 46: 1978-1984. http://dx.doi.org/10.1128/JCM.02246-07.
122. Sun W, Wang K, Gao W, Su X, Qian Q, Lu X, Song Y, Guo Y, Shi Y. 2011. Evaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate metaanalysis and systematic review. PLoS One 6:e28467. http://dx.doi.org/10.1371/journal.pone.0028467.
123. Miyajima Y, Satoh K, Umeda Y, Makimura K. 2009. Quantitation of fungal DNA contamination in commercial zymolyase and lyticase used in the preparation of fungi. Nihon Ishinkin Gakkai Zasshi 50:259-262. http://dx.doi.org/10.3314/jjmm.50.259.
124. Harrison E, Stalhberger T, Whelan R, Sugrue M, Wingard JR, Alexander BD, Follett SA, Bowyer P, Denning DW, Aspergillus Technology Consortium. 2010. Aspergillus DNA contamination in blood collection tubes. Diagn. Microbiol. Infect. Dis. 67:392-394. http://dx.doi.org/10.1016/j.diagmicrobio.2010.02.028.
125. Kourkoumpetis TK, Fuchs BB, Coleman JJ, Desalermos A, Mylonakis E. 2012. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin. Infect. Dis. 54:1322-1331. http://dx.doi.org/10.1093/cid/cis132.
126. Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M, Seifarth W, Leib-Moesch C, Hehlmann R. 2001. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin. Infect. Dis. 33:428-435. http://dx.doi.org/10.1086 /321887.
127. Raad I, Hanna H, Sumoza D, Albitar M. 2002. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients. Cancer 94:1032-1036. http://dx.doi.org/10.1002/cncr.10349.
128. Buchheidt D, Baust C, Skladny H, Baldus M, Brauninger S, Hehlmann R. 2002. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br. J. Haematol. 116:803-811. http://dx.doi.org/10.1046/j.0007-1048.2002.03337.x.
129. Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. 2002. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest 121:1171-1176. http://dx.doi.org/10.1378/chest.121.4.1171.
130. Lass-Flörl C, Gunsilius E, Gastl G, Bonatti H, Freund MC, Gschwendtner A, Kropshofer G, Dierich MP, Petzer A. 2004. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J. Clin. Microbiol. 42:4154-4157. http://dx.doi.org/10.1128/JCM.42.9.4154-4157.2004.
131. Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Schwerdtfeger R, Cornely OA, Wilhelm S, Reuter S, Kern W, Sudhoff T, Morz H, Hehlmann R. 2004. Prospective clinical evaluation of a LightCyclermediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br. J. Haematol. 125:196-202. http://dx.doi.org/10.1111/j.1365-2141.2004.04904.x.
132. Scotter JM, Chambers ST. 2005. Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate. Clin. Vaccine Immunol. 12:1322-1327. http://dx.doi.org/10.1128/CDLI.12.11.1322-1327.2005.
133. Lass-Flörl C, Gunsilius E, Gastl G, Freund M, Dierich MP, Petzer A. 2005. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses 48(Suppl 1):12-17. http://dx.doi.org/10.1111/j.1439-0507.2005.01104.x.
134. Halliday C, Hoile R, Sorrell T, James G, Yadav S, Shaw P, Bleakley M, Bradstock K, Chen S. 2006. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br. J. Haematol. 132:478-486. http://dx.doi.org/10.1111/j.1365-2141.2005.05887.x.
135. Florent M, Katsahian S, Vekhoff A, Levy V, Rio B, Marie JP, Bouvet A, Cornet M. 2006. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J. Infect. Dis. 193:741-747. http://dx.doi.org/10.1086 /500466.
136. Hummel M, Spiess B, Kentouche K, Niggemann S, Bohm C, Reuter S, Kiehl M, Morz H, Hehlmann R, Buchheidt D. 2006. Detection of AspergillusDNAin cerebrospinal fluid from patients with cerebral aspergillosis by a nestedPCRassay. J. Clin. Microbiol. 44:3989-3993. http://dx.doi.org/10.1128/JCM.00466-06.
137. Badiee P, Kordbacheh P, Alborzi A, Ramzi M, Shakiba E. 2008. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection 36:580-584. http://dx.doi.org/10.1007/s15010-008-7385-8.
138. Shahid M, Malik A, Bhargava R. 2008. Bronchogenic carcinoma and secondary aspergillosis-common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis. Cancer 113:547-558. http://dx.doi.org/10.1002/cncr.23570.
139. Hummel M, Spiess B, Roder J, von Komorowski G, Durken M, Kentouche K, Laws HJ, Morz H, Hehlmann R, Buchheidt D. 2009. Detection of AspergillusDNAby a nestedPCRassay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J. Med. Microbiol. 58:1291-1297. http://dx.doi.org/10.1099/jmm.0.007393-0.
140. Lopes da Silva R, Ribeiro P, Abreu N, Ferreira T, Fernandes T, Monteiro A, Costa F, Caldas J, Silva M, Carande L, Ferreira G, Conduto A, Cruz E, Sousa MH, Rodrigues AS, Costa I, Veiga J, de Sousa AB. 2010. Early diagnosis of invasive aspergillosis in neutropenic patients. Comparison between serum galactomannan and polymerase chain reaction. Clin. Med. Insights Oncol. 4:81-88.
141. Hummel M, Spiess B, Cornely OA, Dittmer M, Morz H, Buchheidt D. 2010. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial. Eur. J. Haematol. 85:164-169. http://dx.doi.org/10.1111/j.1600-0609.2010.01452.x.
142. Badiee P, Alborzi A, Karimi M, Pourabbas B, Haddadi P, Mardaneh J, Moieni M. 2012. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. J. Infect. Dev. Ctries. 6:352-357. http://dx.doi.org/10.3855/jidc.2110.
143. Reinwald M, Hummel M, Kovalevskaya E, Spiess B, Heinz WJ, Vehreschild JJ, Schultheis B, Krause SW, Claus B, Suedhoff T, Schwerdtfeger R, Reuter S, Kiehl MG, Hofmann WK, Buchheidt D. 2012. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J. Antimicrob. Chemother. 67:2260-2267. http://dx.doi.org/10.1093/jac/dks208.
144. Reinwald M, Spiess B, Heinz WJ, Vehreschild JJ, Lass-Flörl C, Kiehl M, Schultheis B, Krause SW, Wolf HH, Bertz H, Maschmeyer G, Hofmann WK, Buchheidt D. 2012. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. Eur. J. Haematol. 89:120-127. http://dx.doi.org/10.1111/j.1600-0609.2012.01806.x.
145. Buess M, Cathomas G, Halter J, Junker L, Grendelmeier P, Tamm M, Stolz D. 2012. Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients. BMC Infect. Dis. 12:237. http://dx.doi.org/10.1186/1471-2334-12-237.
146. Costa C, Costa JM, Desterke C, Botterel F, Cordonnier C, Bretagne S. 2002. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 40:2224-2227. http://dx.doi.org/10.1128/JCM.40.6.2224-2227.2002.
147. Spiess B, Buchheidt D, Baust C, Skladny H, Seifarth W, Zeilfelder U, Leib-Mosch C, Morz H, Hehlmann R. 2003. Development of a LightCycler PCRassay for detection and quantification of Aspergillus fumigatusDNAin clinical samples from neutropenic patients. J. Clin. Microbiol. 41:1811-1818. http://dx.doi.org/10.1128/JCM.41.5.1811-1818.2003.
148. Sanguinetti M, Posteraro B, Pagano L, Pagliari G, Fianchi L, Mele L, La Sorda M, Franco A, Fadda G. 2003. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzymelinked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J. Clin. Microbiol. 41:3922-3925. http://dx.doi.org/10.1128/JCM.41.8.3922-3925.2003.
149. Rantakokko-Jalava K, Laaksonen S, Issakainen J, Vauras J, Nikoskelainen J, Viljanen MK, Salonen J. 2003. Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis. J. Clin. Microbiol. 41:4304-4311. http://dx.doi.org/10.1128/JCM.41.9.4304-4311.2003.
150. Challier S, Boyer S, Abachin E, Berche P. 2004. Development of a serumbased Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 42:844-846. http://dx.doi.org/10.1128/JCM.42.2.844-846.2004.
151. Millon L, Piarroux R, Deconinck E, Bulabois CE, Grenouillet F, Rohrlich P, Costa JM, Bretagne S. 2005. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J. Clin. Microbiol. 43:5097-5101. http://dx.doi.org/10.1128 /JCM.43.10.5097-5101.2005.
152. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. 2006. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis. 42:479-486. http://dx.doi.org /10.1086/499949.
153. Cesaro S, Stenghele C, Calore E, Franchin E, Cerbaro I, Cusinato R, Tridello G, Manganelli R, Carli M, Palu G. 2008. Assessment of the Lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses 51:497-504. http: //dx.doi.org/10.1111/j.1439-0507.2008.01512.x.
154. Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S. 2008. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl. Infect. Dis. 10:333-338. http://dx.doi.org/10.1111/j.1399-3062.2008.00323.x.
155. Suarez F, Lortholary O, Buland S, Rubio MT, Ghez D, Mahe V, Quesne G, Poiree S, Buzyn A, Varet B, Berche P, Bougnoux ME. 2008. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in highrisk adult patients under hematologic surveillance. J. Clin. Microbiol. 46:3772-3777. http://dx.doi.org/10.1128/JCM.01086-08.
156. Khot PD, Ko DL, Hackman RC, Fredricks DN. 2008. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect. Dis. 8:73. http://dx.doi.org/10.1186/1471-2334-8-73.
157. Ramirez M, Castro C, Palomares JC, Torres MJ, Aller AI, Ruiz M, Aznar J, Martin-Mazuelos E. 2009. Molecular detection and identification of Aspergillus spp. from clinical samples using real-time PCR. Mycoses 52:129-134. http://dx.doi.org/10.1111/j.1439-0507.2008.01548.x.
158. Frealle E, Decrucq K, Botterel F, Bouchindhomme B, Camus D, Dei-Cas E, Costa JM, Yakoub-Agha I, Bretagne S, Delhaes L. 2009. Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance. Eur. J. Clin. Microbiol. Infect. Dis. 28:223-232. http://dx.doi.org/10.1007/s10096-008-0616-1.
159. Cuenca-Estrella M, Meije Y, Diaz-Pedroche C, Gomez-Lopez A, Buitrago MJ, Bernal-Martinez L, Grande C, Juan RS, Lizasoain M, Rodriguez-Tudela JL, Aguado JM. 2009. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J. Clin. Microbiol. 47:379-384. http://dx.doi.org/10.1128/JCM.01716-08.
160. Millon L, Grenouillet F, Legrand F, Loewert S, Bellanger AP, Gbaguidi-Haore H, Scherer E, Henon T, Rohrlich P, Deconinck E. 2011. Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosis. J. Clin. Microbiol. 49:1058-1063. http://dx.doi.org/10.1128/JCM.01904-10.
161. White PL, Perry MD, Moody A, Follett SA, Morgan G, Barnes RA. 2011. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 49:2169-2174. http://dx.doi.org/10.1128/JCM.00101-11.
162. Bernal-Martinez L, Gago S, Buitrago MJ, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. 2011. Analysis of performance of a PCRbased assay to detect DNA of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samples. J. Clin. Microbiol. 49:3596-3599. http://dx.doi.org/10.1128/JCM.00647-11.
163. Luong ML, Clancy CJ, Vadnerkar A, Kwak EJ, Silveira FP, Wissel MC, Grantham KJ, Shields RK, Crespo M, Pilewski J, Toyoda Y, Kleiboeker SB, Pakstis D, Reddy SK, Walsh TJ, Nguyen MH. 2011. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin. Infect. Dis. 52:1218-1226. http://dx.doi.org/10.1093/cid/cir185.
164. Torelli R, Sanguinetti M, Moody A, Pagano L, Caira M, De Carolis E, Fuso L, De Pascale G, Bello G, Antonelli M, Fadda G, Posteraro B. 2011. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J. Clin. Microbiol. 49:4273-4278. http://dx.doi.org/10.1128/JCM.05026-11.
165. Springer J, Morton CO, Perry M, Heinz WJ, Paholcsek M, Alzheimer M, Rogers TR, Barnes RA, Einsele H, Loeffler J, White PL. 2013. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. J. Clin. Microbiol. 51:1445-1450. http://dx.doi.org/10.1128/JCM.03322-12.
166. Rogers TR, Morton CO, Springer J, Conneally E, Heinz W, Kenny C, Frost S, Einsele H, Loeffler J. 2013. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies. Br. J. Haematol. 161:517-524. http://dx.doi.org/10.1111/bjh.12285.
167. Li Y, Gao L, Ding Y, Xu Y, Zhou M, Huang W, Jing Y, Li H, Wang L, Yu L. 2013. Establishment and application of real-time quantitative PCR for diagnosing invasive aspergillosis via the blood in hematological patients: targeting a specific sequence of Aspergillus 28S-ITS2. BMC Infect. Dis. 13:255. http://dx.doi.org/10.1186/1471-2334-13-255.
168. Guinea J, Padilla C, Escribano P, Munoz P, Padilla B, Gijon P, Bouza E. 2013. Evaluation of MycAssay Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. PLoS One 8:e61545. http://dx.doi.org/10.1371/journal.pone.0061545.
169. Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mosch C, Hehlmann R. 1999. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J. Clin. Microbiol. 37:3865-3871.
170. White PL, Barton R, Guiver M, Linton CJ, Wilson S, Smith M, Gomez BL, Carr MJ, Kimmitt PT, Seaton S, Rajakumar K, Holyoake T, Kibbler CC, Johnson E, Hobson RP, Jones B, Barnes RA. 2006. A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J. Mol. Diagn. 8:376-384. http: //dx.doi.org/10.2353/jmoldx.2006.050120.
171. White PL, Mengoli C, Bretagne S, Cuenca-Estrella M, Finnstrom N, Klingspor L, Melchers WJ, McCulloch E, Barnes RA, Donnelly JP, Loeffler J, European Aspergillus PCR Initiative. 2011. Evaluation of Aspergillus PCR protocols for testing serum specimens. J. Clin. Microbiol. 49:3842-3848. http://dx.doi.org/10.1128/JCM.05316-11.
172. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:89-96. http://dx.doi.org/10.1016 /S1473-3099(09)70019-2.
173. Loeffler J, Hebart H, Brauchle U, Schumacher U, Einsele H. 2000. Comparison between plasma and whole blood specimens for detection of Aspergillus DNA by PCR. J. Clin. Microbiol. 38:3830-3833.
174. Garcia ME, Blanco JL, Caballero J, Gargallo-Viola D. 2002. Anticoagulants interfere withPCRused to diagnose invasive aspergillosis. J. Clin. Microbiol. 40:1567-1568. http://dx.doi.org/10.1128/JCM.40.4.1567-1568.2002.
175. Mennink-Kersten MA, Ruegebrink D, Wasei N, Melchers WJ, Verweij PE. 2006. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 44:1711-1718. http://dx.doi.org/10.1128/JCM.44.5.1711-1718.2006.
176. Francesconi A, Kasai M, Petraitiene R, Petraitis V, Kelaher AM, Schaufele R, Hope WW, Shea YR, Bacher J, Walsh TJ. 2006. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J. Clin. Microbiol. 44:2475-2480. http://dx.doi.org/10.1128 /JCM.02693-05.
177. Lass-Flörl C, Speth C, Mayr A, Wurzner R, Dierich MP, Ulmer H, Dietrich H. 2003. Diagnosing and monitoring of invasive aspergillosis during antifungal therapy by polymerase chain reaction: an experimental study in mice. Diagn. Microbiol. Infect. Dis. 47:569-572. http://dx.doi.org/10.1016/S0732-8893(03)00168-8.
178. Springer J, Schlossnagel H, Heinz W, Doedt T, Soeller R, Einsele H, Loeffler J. 2012. A novel extraction method combining plasma with a whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis. J. Clin. Microbiol. 50:2585-2591. http://dx.doi.org/10.1128/JCM.00523-12.
179. McCulloch E, Ramage G, Rajendran R, Lappin DF, Jones B, Warn P, Shrief R, Kirkpatrick WR, Patterson TF, Williams C. 2012. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. J. Clin. Pathol. 65:83-86. http://dx.doi.org/10.1136/jcp.2011.090464.
180. Avni T, Levy I, Sprecher H, Yahav D, Leibovici L, Paul M. 2012. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. J. Clin. Microbiol. 50:3652-3658. http://dx.doi.org/10.1128/JCM.00942-12.
181. Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Moore J, Schwarer AP, Guy S, Bajel A, Tramontana AR, Spelman T, Slavin MA, Australasian Leukaemia Lymphoma Group, New Zealand Mycology Interest Group. 2013. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect. Dis. 13:519-528. http://dx.doi.org/10.1016/S1473-3099(13)70076-8.
182. White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, Finnstrom N, Mengoli C, Barnes RA, Donnelly JP, Loeffler J, European Aspergillus PCR Initiative. 2010. Aspergillus PCR: one step closer to standardization. J. Clin. Microbiol. 48:1231-1240. http://dx.doi.org/10.1128/JCM.01767-09.
183. White PL, Perry MD, Loeffler J, Melchers W, Klingspor L, Bretagne S, McCulloch E, Cuenca-Estrella M, Finnstrom N, Donnelly JP, Barnes RA, European Aspergillus PCR Initiative. 2010. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J. Clin. Microbiol. 48:3753-3755. http://dx.doi.org/10.1128/JCM.01466-10.
184. Lyon GM, Abdul-Ali D, Loeffler J, White PL, Wickes B, Herrera ML, Alexander BD, Baden LR, Clancy C, Denning D, Nguyen MH, Sugrue M, Wheat LJ, Wingard JR, Donnelly JP, Barnes R, Patterson TF, Caliendo AM, aAsTeC, IAAM, EAPCRI Investigators. 2013. Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis. J. Clin. Microbiol. 51:2403-2405. http://dx.doi.org/10.1128/JCM.00744-13.
185. Ahmad S, Khan Z, Mustafa AS, Khan ZU. 2002. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J. Clin. Microbiol. 40:2483-2489. http://dx.doi.org/10.1128/JCM.40.7.2483-2489.2002.
186. White PL, Shetty A, Barnes RA. 2003. Detection of seven Candida species using the Light-Cycler system. J. Med. Microbiol. 52:229-238. http://dx.doi.org/10.1099/jmm.0.05049-0.
187. Tirodker UH, Nataro JP, Smith S, LasCasas L, Fairchild KD. 2003. Detection of fungemia by polymerase chain reaction in critically ill neonates and children. J. Perinatol. 23:117-122. http://dx.doi.org/10.1038/sj.jp.7210868.
188. Maaroufi Y, Ahariz N, Husson M, Crokaert F. 2004. Comparison of different methods of isolation of DNA of commonly encountered Candida species and its quantitation by using a real-time PCR-based assay. J. Clin. Microbiol. 42:3159-3163. http://dx.doi.org/10.1128/JCM.42.7.3159-3163.2004.
189. Ahmad S, Mustafa AS, Khan Z, Al-Rifaiy AI, Khan ZU. 2004. PCRenzyme immunoassay ofrDNAin the diagnosis of candidemia and comparison with amplicon detection by agarose gel electrophoresis. Int. J. Med. Microbiol. 294:45-51. http://dx.doi.org/10.1016/j.ijmm.2004.01.002.
190. White PL, Archer AE, Barnes RA. 2005. Comparison of non-culturebased methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J. Clin. Microbiol. 43:2181-2187. http://dx.doi.org/10.1128/JCM.43.5.2181-2187.2005.
191. Moreira-Oliveira MS, Mikami Y, Miyaji M, Imai T, Schreiber AZ, Moretti ML. 2005. Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia. Eur. J. Clin. Microbiol. Infect. Dis. 24:721-726. http://dx.doi.org/10.1007/s10096-005-0041-7.
192. Alam FF, Mustafa AS, Khan ZU. 2007. Comparative evaluation of (1,3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect. Dis. 7:103. http://dx.doi.org/10.1186/1471-2334-7-103.
193. McMullan R, Metwally L, Coyle PV, Hedderwick S, McCloskey B, O'Neill HJ, Patterson CC, Thompson G, Webb CH, Hay RJ. 2008. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin. Infect. Dis. 46:890-896. http://dx.doi.org/10.1086/528690.
194. Dunyach C, Bertout S, Phelipeau C, Drakulovski P, Reynes J, Mallie M. 2008. Detection and identification of Candida spp. in human serum by LightCycler real-time polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 60:263-271. http://dx.doi.org/10.1016/j.diagmicrobio.2007.09.014.
195. Metwally L, Fairley DJ, Coyle PV, Hay RJ, Hedderwick S, McCloskey B, O'Neill HJ, Webb CH, McMullan R. 2008. Comparison of serum and whole-blood specimens for the detection of CandidaDNAin critically ill, non-neutropenic patients. J. Med. Microbiol. 57:1269-1272. http://dx.doi.org/10.1099/jmm.0.2008/002444-0.
196. Badiee P, Kordbacheh P, Alborzi A, Zakernia M, Haddadi P. 2009. Early detection of systemic candidiasis in the whole blood of patients with hematologic malignancies. Jpn. J. Infect. Dis. 62:1-5.
197. Khlif M, Mary C, Sellami H, Sellami A, Dumon H, Ayadi A, Ranque S. 2009. Evaluation of nested and real-time PCR assays in the diagnosis of candidaemia. Clin. Microbiol. Infect. 15:656-661. http://dx.doi.org/10.1111/j.1469-0691.2009.02762.x.
198. Wellinghausen N, Siegel D, Winter J, Gebert S. 2009. Rapid diagnosis of candidaemia by real-time PCR detection of Candida DNA in blood samples. J. Med. Microbiol. 58:1106-1111. http://dx.doi.org/10.1099 /jmm.0.007906-0.
199. Badiee P, Alborzi A, Vojdani R, Shakiba E, Rasouli M, Ravanfar P, Haddadi P. 2010. Early diagnosis of systemic candidiasis in bone marrow transplant recipients. Exp. Clin. Transplant. 8:98-103.
200. Lau A, Halliday C, Chen SC, Playford EG, Stanley K, Sorrell TC. 2010. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J. Clin. Microbiol. 48:811-816. http://dx.doi.org/10.1128/JCM.01650-09.
201. Schell WA, Benton JL, Smith PB, Poore M, Rouse JL, Boles DJ, Johnson MD, Alexander BD, Pamula VK, Eckhardt AE, Pollack MG, Benjamin DK, Jr, Perfect JR, Mitchell TG. 2012. Evaluation of a digital microfluidic real-time PCR platform to detect DNA of Candida albicans in blood. Eur. J. Clin. Microbiol. Infect. Dis. 31:2237-2245. http://dx.doi.org/10.1007/s10096-012-1561-6.
202. Trovato L, Betta P, Romeo MG, Oliveri S. 2012. Detection of fungal DNA in lysis-centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients. Clin. Microbiol. Infect. 18:E63-E65. http://dx.doi.org/10.1111/j.1469-0691.2011.03731.x.
203. Avni T, Leibovici L, Paul M. 2011. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J. Clin. Microbiol. 49:665-670. http://dx.doi.org/10.1128/JCM.01602-10.
204. Kasai M, Francesconi A, Petraitiene R, Petraitis V, Kelaher AM, Kim HS, Meletiadis J, Sein T, Bacher J, Walsh TJ. 2006. Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive candidiasis. J. Clin. Microbiol. 44:143-150. http://dx.doi.org/10.1128/JCM.44.1.143-150.2006.
205. Selvarangan R, Bui U, Limaye AP, Cookson BT. 2003. Rapid identification of commonly encountered Candida species directly from blood culture bottles. J. Clin. Microbiol. 41:5660-5664. http://dx.doi.org/10.1128/JCM.41.12.5660-5664.2003.
206. Shin JH, Nolte FS, Morrison CJ. 1997. Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J. Clin. Microbiol. 35:1454-1459.
207. Metwally L, Hogg G, Coyle PV, Hay RJ, Hedderwick S, McCloskey B, O'Neill HJ, Ong GM, Thompson G, Webb CH, McMullan R. 2007. Rapid differentiation between fluconazole-sensitive and-resistant species of Candida directly from positive blood-culture bottles by real-time PCR. J. Med. Microbiol. 56:964-970. http://dx.doi.org/10.1099/jmm.0.47149-0.
208. Pryce TM, Palladino S, Price DM, Gardam DJ, Campbell PB, Christiansen KJ, Murray RJ. 2006. Rapid identification of fungal pathogens in BacT/ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions. Diagn. Microbiol. Infect. Dis. 54:289-297. http://dx.doi.org/10.1016/j.diagmicrobio.2005.11.002.
209. Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. 29 May 2013. Echinocandin and triazole antifungal susceptibility profiles of opportunistic yeast and mould clinical isolates (2010-2011): application of new CLSI clinical breakpoints and epidemiological cutoff values to characterize geographic and temporal trends of antifungal resistance. J. Clin. Microbiol. http://dx.doi.org/10.1128/JCM.00308-13.
210. Clancy CJ, Nguyen MH. 2013. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin. Infect. Dis. 56:1284-1292. http://dx.doi.org/10.1093/cid/cit006.
211. Balashov SV, Park S, Perlin DS. 2006. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob. Agents Chemother. 50:2058-2063. http://dx.doi.org/10.1128/AAC.01653-05.
212. Frade JP, Warnock DW, Arthington-Skaggs BA. 2004. Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization. J. Clin. Microbiol. 42:2085-2093. http://dx.doi.org/10.1128 /JCM.42.5.2085-2093.2004.
213. Gygax SE, Vermitsky JP, Chadwick SG, Self MJ, Zimmerman JA, Mordechai E, Adelson ME, Trama JP. 2008. Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay. Antimicrob. Agents Chemother. 52:3424-3426. http://dx.doi.org/10.1128 /AAC.00462-08.
214. Morris A, Norris KA. 2012. Colonization by Pneumocystis jirovecii and its role in disease. Clin. Microbiol. Rev. 25:297-317. http://dx.doi.org/10.1128/CMR.00013-12.
215. Maher NH, Vermund SH, Welsh DA, Dillon HK, Awooda A, Unnasch TR. 2001. Development and characterization of a molecular viability assay for Pneumocystis carinii f sp hominis. J. Infect. Dis. 183:1825-1827. http://dx.doi.org/10.1086/320738.
216. Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, Lucht F, Sung RT. 2004. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jirovecii pneumonia from bronchoalveolar lavage specimens. J. Med. Microbiol. 53:603-607. http://dx.doi.org/10.1099/jmm.0.45528-0.
217. Alvarez-Martinez MJ, Miro JM, Valls ME, Moreno A, Rivas PV, Sole M, Benito N, Domingo P, Munoz C, Rivera E, Zar HJ, Wissmann G, Diehl AR, Prolla JC, de Anta MT, Gatell JM, Wilson PE, Meshnick SR, Spanish PCP Working Group. 2006. Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jirovecii in clinical specimens. Diagn. Microbiol. Infect. Dis. 56:153-160. http://dx.doi.org /10.1016/j.diagmicrobio.2006.03.010.
218. de Oliveira A, Unnasch TR, Crothers K, Eiser S, Zucchi P, Moir J, Beard CB, Lawrence GG, Huang L. 2007. Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIVinfected patients. Diagn. Microbiol. Infect. Dis. 57:169-176. http://dx.doi.org/10.1016/j.diagmicrobio.2006.08.015.
219. Etoh K. 2008. Evaluation of a real-time PCR assay for the diagnosis of Pneumocystis pneumonia. Kurume Med. J. 55:55-62. http://dx.doi.org /10.2739/kurumemedj.55.55.
220. Huggett JF, Taylor MS, Kocjan G, Evans HE, Morris-Jones S, Gant V, Novak T, Costello AM, Zumla A, Miller RF. 2008. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients. Thorax 63:154-159. http://dx.doi.org/10.1136/thx.2007.081687.
221. Gupta R, Mirdha BR, Guleria R, Kumar L, Samantaray JC, Agarwal SK, Kabra SK, Luthra K. 2009. Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimens. Diagn. Microbiol. Infect. Dis. 64:381-388. http://dx.doi.org/10.1016/j.diagmicrobio.2009.04.008.
222. Fujisawa T, Suda T, Matsuda H, Inui N, Nakamura Y, Sato J, Toyoshima M, Nakano Y, Yasuda K, Gemma H, Hayakawa H, Chida K. 2009. Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection. Respirology 14:203-209. http://dx.doi.org/10.1111/j.1440-1843.2008.01457.x.
223. Tia T, Putaporntip C, Kosuwin R, Kongpolprom N, Kawkitinarong K, Jongwutiwes S. 2012. A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveloar lavage specimens from immunocompromised patients. Clin. Microbiol. Infect. 18:598-603. http://dx.doi.org/10.1111/j.1469-0691.2011.03656.x.
224. Muhlethaler K, Bogli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, Muhlemann K, Garzoni C. 2012. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur. Respir. J. 39:971-978. http://dx.doi.org/10.1183/09031936.00095811.
225. Khodadadi H, Mirhendi H, Mohebali M, Kordbacheh P, Zarrinfar H, Makimura K. 2013. Pneumocystis jirovecii colonization in non-HIVinfected patients based on nested-PCR detection in bronchoalveolar lavage samples. Iran J. Public Health 42:298-305.
226. Josephson KL, Gerba CP, Pepper IL. 1993. Polymerase chain reaction detection of nonviable bacterial pathogens. Appl. Environ. Microbiol. 59:3513-3515.
227. Maher N, Vermund S, Lasbury M, Lee C, Bartlett M, Unnasch TR. 2000. Development and evaluation of a molecular viability assay for Pneumocystis carinii. J. Clin. Microbiol. 38:1947-1952.
228. Lu Y, Ling G, Qiang C, Ming Q, Wu C, Wang K, Ying Z. 2011. PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis. J. Clin. Microbiol. 49:4361-4363. http://dx.doi.org/10.1128/JCM.06066-11.
229. Hata DJ, Buckwalter SP, Pritt BS, Roberts GD, Wengenack NL. 2008. Real-time PCR method for detection of zygomycetes. J. Clin. Microbiol. 46:2353-2358. http://dx.doi.org/10.1128/JCM.02331-07.
230. Nagao K, Ota T, Tanikawa A, Takae Y, Mori T, Udagawa S, Nishikawa T. 2005. Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene. J. Dermatol. Sci. 39:23-31. http://dx.doi.org/10.1016/j.jdermsci.2005.01.010.
231. Kasai M, Harrington SM, Francesconi A, Petraitis V, Petraitiene R, Beveridge MG, Knudsen T, Milanovich J, Cotton MP, Hughes J, Schaufele RL, Sein T, Bacher J, Murray PR, Kontoyiannis DP, Walsh TJ. 2008. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J. Clin. Microbiol. 46:3690-3702. http://dx.doi.org/10.1128/JCM.00917-08.
232. Dannaoui E, Schwarz P, Slany M, Loeffler J, Jorde AT, Cuenca-Estrella M, Hauser PM, Shrief R, Huerre M, Freiberger T, Gaustad P, Rodriguez-Tudela JL, Bille J, Denning DW, Bretagne S, Lortholary O. 2010. Molecular detection and identification of Zygomycetes species from paraffinembedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation. J. Clin. Microbiol. 48:2043-2046. http://dx.doi.org/10.1128/JCM.02319-09.
233. Castelli MV, Buitrago MJ, Bernal-Martinez L, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. 2008. Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. J. Clin. Microbiol. 46:3412-3416. http://dx.doi.org/10.1128/JCM.00046-08.
234. Rappelli P, Are R, Casu G, Fiori PL, Cappuccinelli P, Aceti A. 1998. Development of a nested PCR for detection of Cryptococcus neoformans in cerebrospinal fluid. J. Clin. Microbiol. 36:3438-3440.
235. Thompson GR, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe EM, Davis M, Libke R, Cohen SH, Pappagianis D. 2013. Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest 143:776-781. http://dx.doi.org/10.1378/chest.12-1312.
236. Sugawara Y, Nakase K, Nakamura A, Ohishi K, Sugimoto Y, Fujieda A, Monma F, Suzuki K, Masuya M, Matsushima Y, Wada H, Nobori T, Katayama N. 2013. Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur. J. Haematol. 90:331-339. http://dx.doi.org/10.1111/ejh.12078.
237. Paterson PJ, Seaton S, McHugh TD, McLaughlin J, Potter M, Prentice HG, Kibbler CC. 2006. Validation and clinical application of molecular methods for the identification of molds in tissue. Clin. Infect. Dis. 42:51-56. http://dx.doi.org/10.1086/498111.
238. Badiee P, Kordbacheh P, Alborzi A, Malekhoseini S, Zeini F, Mirhendi H, Mahmoodi M. 2007. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transpl. 13:1011-1016. http://dx.doi.org/10.1002/lt.21175.
239. Vollmer T, Stormer M, Kleesiek K, Dreier J. 2008. Evaluation of novel broad-range real-time PCR assay for rapid detection of human pathogenic fungi in various clinical specimens. J. Clin. Microbiol. 46:1919-1926. http://dx.doi.org/10.1128/JCM.02178-07.
240. Imhof A, Schaer C, Schoedon G, Schaer DJ, Walter RB, Schaffner A, Schneemann M. 2003. Rapid detection of pathogenic fungi from clinical specimens using LightCycler real-time fluorescence PCR. Eur. J. Clin. Microbiol. Infect. Dis. 22:558-560. http://dx.doi.org/10.1007/s10096-003-0989-0.
241. Rickerts V, Just-Nubling G, Konrad F, Kern J, Lambrecht E, Bohme A, Jacobi V, Bialek R. 2006. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur. J. Clin. Microbiol. Infect. Dis. 25:8-13. http://dx.doi.org/10.1007/s10096-005-0078-7.
242. Rickerts V, Mousset S, Lambrecht E, Tintelnot K, Schwerdtfeger R, Presterl E, Jacobi V, Just-Nubling G, Bialek R. 2007. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin. Infect. Dis. 44:1078-1083. http://dx.doi.org/10.1086/512812.
243. Badiee P, Kordbacheh P, Alborzi A, Malekhoseini S, Ramzi M, Mirhendi H, Mahmoodi M, Shakiba E. 2009. Study on invasive fungal infections in immunocompromised patients to present a suitable early diagnostic procedure. Int. J. Infect. Dis. 13:97-102. http://dx.doi.org/10.1016/j.ijid.2008.04.011.
244. Ribeiro P, Costa F, Monteiro A, Caldas J, Silva M, Ferreira G, Veiga J, Sousa MO, Viegas MP, Santos E, Goncalves AJ, Sousa AB. 2006. Polymerase chain reaction screening for fungemia and/or invasive fungal infections in patients with hematologic malignancies. Support Care Cancer 14:469-474. http://dx.doi.org/10.1007/s00520-005-0903-7.
245. Pryce TM, Kay ID, Palladino S, Heath CH. 2003. Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole blood from high-risk patients. Diagn. Microbiol. Infect. Dis. 47:487-496. http://dx.doi.org/10.1016/S0732-8893(03)00139-1.
246. Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. 2003. Diagnosis of invasive mold infection by real-time quantitative PCR. Am. J. Clin. Pathol. 119:38-44. http://dx.doi.org/10.1309 /RQ05PP9NEG6DADXR.
247. Orsi CF, Gennari W, Venturelli C, La Regina A, Pecorari M, Righi E, Machetti M, Blasi E. 2012. Performance of 2 commercial real-time polymerase chain reaction assays for the detection of Aspergillus and Pneumocystis DNA in bronchoalveolar lavage fluid samples from critical care patients. Diagn. Microbiol. Infect. Dis. 73:138-143. http://dx.doi.org/10.1016/j.diagmicrobio.2012.03.001.
248. Mauro MV, Cavalcanti P, Perugini D, Noto A, Sperli D, Giraldi C. 2012. Diagnostic utility of LightCycler SeptiFast and procalcitonin assays in the diagnosis of bloodstream infection in immunocompromised patients. Diagn. Microbiol. Infect. Dis. 73:308-311. http://dx.doi.org/10.1016/j.diagmicrobio.2012.04.006.
249. Georgiadou SP, Kontoyiannis DP. 2012. Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis? J. Infect. 65:262-268. http: //dx.doi.org/10.1016/j.jinf.2012.05.001.
250. Lamoth F, Jaton K, Prod'hom G, Senn L, Bille J, Calandra T, Marchetti O. 2010. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J. Clin. Microbiol. 48:3510-3516. http://dx.doi.org/10.1128/JCM.00147-10.
251. Lucignano B, Ranno S, Liesenfeld O, Pizzorno B, Putignani L, Bernaschi P, Menichella D. 2011. Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis. J. Clin. Microbiol. 49:2252-2258. http://dx.doi.org/10.1128/JCM.02460-10.
252. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA. 2012. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the Film-Array system. Diagn. Microbiol. Infect. Dis. 74:349-355. http://dx.doi.org/10.1016/j.diagmicrobio.2012.08.013.
253. Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J, Fontaine E, Chu A, Carothers B, Reilly A, Fiedler J, Wiese AD, Feaster C, Gibson L, Griese S, Purfield A, Cleveland AA, Benedict K, Harris JR, Brandt ME, Blau D, Jernigan J, Weber JT, Park BJ, Multistate Fungal Infection Outbreak Response Team. 2013. Fungal infections associated with contaminated methylprednisolone injections. N. Engl. J. Med. 369:1598-1609. http://dx.doi.org/10.1056/NEJMoa1213978.
254. Lockhart SR, Pham CD, Gade L, Iqbal N, Scheel CM, Cleveland AA, Whitney AM, Noble-Wang J, Chiller TM, Park BJ, Litvintseva AP, Brandt ME. 2013. Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections. J. Clin. Microbiol. 51:2654-2661. http://dx.doi.org/10.1128/JCM.01000-13.
255. Wilson DA, Joyce MJ, Hall LS, Reller LB, Roberts GD, Hall GS, Alexander BD, Procop GW. 2005. Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J. Clin. Microbiol. 43:2909-2912. http://dx.doi.org/10.1128/JCM.43.6.2909-2912.2005.
256. Rickerts V, Khot PD, Myerson D, Ko DL, Lambrecht E, Fredricks DN. 2011. Comparison of quantitative real time PCR with sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens. BMC Infect. Dis. 11:202. http://dx.doi.org/10.1186/1471-2334-11-202.
257. Montone KT, Litzky LA, Feldman MD, Peterman H, Mathis B, Baliff J, Kaiser LR, Kucharczuk J, Nachamkin I. 2010. In situ hybridization for Coccidioides immitis 5.8S ribosomalRNAsequences in formalin-fixed, paraffin-embedded pulmonary specimens using a locked nucleic acid probe: a rapid means for identification in tissue sections. Diagn. Mol. Pathol. 19:99-104. http://dx.doi.org/10.1097/PDM.0b013e3181b3aa55.
258. Montone KT, LiVolsi VA, Lanza DC, Kennedy DW, Palmer J, Chiu AG, Feldman MD, Loevner LA, Nachamkin I. 2011. In situ hybridization for specific fungal organisms in acute invasive fungal rhinosinusitis. Am. J. Clin. Pathol. 135:190-199. http://dx.doi.org/10.1309 /AJCPQLYZBDF30HTM.
259. Compton J. 1991. Nucleic acid sequence-based amplification. Nature 350:91-92. http://dx.doi.org/10.1038/350091a0.
260. Yoo JH, Choi JH, Choi SM, Lee DG, Shin WS, Min WS, Kim CC. 2005. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 40:392-398. http://dx.doi.org/10.1086/427284.
261. Loeffler J, Hebart H, Cox P, Flues N, Schumacher U, Einsele H. 2001. Nucleic acid sequence-based amplification of Aspergillus RNA in blood samples. J. Clin. Microbiol. 39:1626-1629. http://dx.doi.org/10.1128 /JCM.39.4.1626-1629.2001.
262. Yoo JH, Choi SM, Lee DG, Park SH, Choi JH, Kwon EY, Shin WS. 2007. Comparison of the real-time nucleic acid sequence-based amplification (RTi-NASBA) with conventional NASBA, and galactomannan assay for the diagnosis of invasive aspergillosis. J. Korean Med. Sci. 22:672-676. http://dx.doi.org/10.3346/jkms.2007.22.4.672.
263. Kim SH, Park C, Kwon EY, Shin NY, Kwon JC, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH. 2012. Real-time nucleic acid sequence-based amplification to predict the clinical outcome of invasive aspergillosis. J. Korean Med. Sci. 27:10-15. http://dx.doi.org/10.3346/jkms.2012.27.1.10.
264. Hettick JM, Green BJ, Buskirk AD, Kashon ML, Slaven JE, Janotka E, Blachere FM, Schmechel D, Beezhold DH. 2008. Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry fingerprinting. Anal. Biochem. 380:276-281. http://dx.doi.org/10.1016/j.ab.2008.05.051.
265. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D. 2009. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-offlight mass spectrometry. Clin. Infect. Dis. 49:543-551. http://dx.doi.org /10.1086/600885.
266. Lacroix C, Gicquel A, Sendid B, Meyer J, Accoceberry I, Francois N, Morio F, Desoubeaux G, Chandenier J, Kauffmann-Lacroix C, Hennequin C, Guitard J, Nassif X, Bougnoux ME. 2014. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry(MALDI-TOFMS)systems for the identification of Candida species. Clin. Microbiol. Infect. 20: 153-158. http://dx.doi.org/10.1111/1469-0691.12210.
267. De Carolis E, Posteraro B, Lass-Flörl C, Vella A, Florio AR, Torelli R, Girmenia C, Colozza C, Tortorano AM, Sanguinetti M, Fadda G. 2012. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-offlight mass spectrometry. Clin. Microbiol. Infect. 18:475-484. http://dx.doi.org/10.1111/j.1469-0691.2011.03599.x.
268. Alanio A, Beretti JL, Dauphin B, Mellado E, Quesne G, Lacroix C, Amara A, Berche P, Nassif X, Bougnoux ME. 2011. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin. Microbiol. Infect. 17:750-755. http://dx.doi.org/10.1111/j.1469-0691.2010.03323.x.
269. Ferroni A, Suarez S, Beretti JL, Dauphin B, Bille E, Meyer J, Bougnoux ME, Alanio A, Berche P, Nassif X. 2010. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48:1542-1548. http://dx.doi.org/10.1128/JCM.02485-09.
270. Ferreira L, Sanchez-Juanes F, Porras-Guerra I, Garcia-Garcia MI, Garcia-Sanchez JE, Gonzalez-Buitrago JM, Munoz-Bellido JL. 2011. Microorganisms direct identification from blood culture by matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17:546-551. http://dx.doi.org/10.1111/j.1469-0691.2010.03257.x.
271. Marklein G, Josten M, Klanke U, Muller E, Horre R, Maier T, Wenzel T, Kostrzewa M, Bierbaum G, Hoerauf A, Sahl HG. 2009. Matrixassisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912-2917. http://dx.doi.org/10.1128/JCM.00389-09.
272. Spanu T, Posteraro B, Fiori B, D'Inzeo T, Campoli S, Ruggeri A, Tumbarello M, Canu G, Trecarichi EM, Parisi G, Tronci M, Sanguinetti M, Fadda G. 2012. Direct matrix-assisted laser desorption ionization-time of flight mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J. Clin. Microbiol. 50:176-179. http://dx.doi.org/10.1128/JCM.05742-11.
273. Yaman G, Akyar I, Can S. 2012. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures. Diagn. Microbiol. Infect. Dis. 73:65-67. http://dx.doi.org/10.1016 /j.diagmicrobio.2012.01.013.
274. Iriart X, Lavergne RA, Fillaux J, Valentin A, Magnaval JF, Berry A, Cassaing S. 2012. Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy. J. Clin. Microbiol. 50:2107-2110. http://dx.doi.org/10.1128/JCM.06713-11.
275. Bille E, Dauphin B, Leto J, Bougnoux ME, Beretti JL, Lotz A, Suarez S, Meyer J, Join-Lambert O, Descamps P, Grall N, Mory F, Dubreuil L, Berche P, Nassif X, Ferroni A. 2012. MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin. Microbiol. Infect. 18: 1117-1125. http://dx.doi.org/10.1111/j.1469-0691.2011.03688.x.
276. Lohmann C, Sabou M, Moussaoui W, Prevost G, Delarbre JM, Candolfi E, Gravet A, Letscher-Bru V. 2013. Comparison between the Biflex III-Biotyper and the Axima-SARAMIS systems for yeast identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 51:1231-1236. http://dx.doi.org/10.1128 /JCM.03268-12.
277. Rosenvinge FS, Dzajic E, Knudsen E, Malig S, Andersen LB, Lovig A, Arendrup MC, Jensen TG, Gahrn-Hansen B, Kemp M. 2013. Performance of matrix-assisted laser desorption-time of flight mass spectrometry for identification of clinical yeast isolates. Mycoses 56:229-235. http: //dx.doi.org/10.1111/myc.12000.
278. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. 2011. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17:1359-1365. http://dx.doi.org /10.1111/j.1469-0691.2010.03398.x.
279. De Carolis E, Vella A, Florio AR, Posteraro P, Perlin DS, Sanguinetti M, Posteraro B. 2012. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species. J. Clin. Microbiol. 50:2479-2483. http://dx.doi.org/10.1128/JCM.00224-12.
280. Vella A, De Carolis E, Vaccaro L, Posteraro P, Perlin DS, Kostrzewa M, Posteraro B, Sanguinetti M. 2013. Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis. J. Clin. Microbiol. 51:2964-2969. http://dx.doi.org/10.1128/JCM.00903-13.
281. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin. Infect. Dis. 57:1237-1245. http://dx.doi.org/10.1093/cid/cit498.
282. Massire C, Buelow DR, Zhang SX, Lovari R, Matthews HE, Toleno DM, Ranken RR, Hall TA, Metzgar D, Sampath R, Blyn LB, Ecker DJ, Gu Z, Walsh TJ, Hayden RT. 2013. PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. J. Clin. Microbiol. 51:959-966. http://dx.doi.org/10.1128 /JCM.02621-12.
283. Shin JH, Ranken R, Sefers SE, Lovari R, Quinn CD, Meng S, Carolan HE, Toleno D, Li H, Lee JN, Stratton CW, Massire C, Tang YW. 2013. Detection, identification, and distribution of fungi in bronchoalveolar lavage specimens by use of multilocus PCR coupled with electrospray ionization/mass spectrometry. J. Clin. Microbiol. 51:136-141. http://dx.doi.org/10.1128/JCM.01907-12.
284. Faulds K, Smith WE, Graham D. 2005. DNA detection by surface enhanced resonance Raman scattering (SERRS). Analyst 130:1125-1131. http://dx.doi.org/10.1039/b500248f.
285. Yoo SM, Kang T, Kang H, Lee H, Kang M, Lee SY, Kim B. 2011. Combining a nanowire SERRS sensor and a target recycling reaction for ultrasensitive and multiplex identification of pathogenic fungi. Small 7:3371-3376. http://dx.doi.org/10.1002/smll.201100633.
286. Ilic B, Czaplewski D, Craighead HG, Neuzil P, Campagnolo C, Batt C. 2000. Mechanical resonant immunospecific biological detector. Appl. Phys. Lett. 77:450-452. http://dx.doi.org/10.1063/1.127006.
287. Gupta A, Akin D, Bashir R. 2004. Single virus particle mass detection using microresonators with nanoscale thickness. Appl. Phys. Lett. 84: 1976-1978. http://dx.doi.org/10.1063/1.1667011.
288. Nugaeva N, Gfeller KY, Backmann N, Lang HP, Duggelin M, Hegner M. 2005. Micromechanical cantilever array sensors for selective fungal immobilization and fast growth detection. Biosens. Bioelectron. 21:849-856. http://dx.doi.org/10.1016/j.bios.2005.02.004.
289. Bloch F. 1946. Nuclear induction. Phys. Rev. 70:460-474.
290. Ernst RR. 1966. Nuclear magnetic double resonance with an incoherent radio-frequency field. J. Chem. Phys. 45:3845. http://dx.doi.org/10.1063 /1.1727409.
291. Lauterbur PC. 1973. Image formation by induced local interactions-examples employing nuclear magnetic-resonance. Nature 242:190-191. http://dx.doi.org/10.1038/242190a0.
292. Bourne R, Himmelreich U, Sharma A, Mountford C, Sorrell T. 2001. Identification of Enterococcus, Streptococcus, and Staphylococcus by multivariate analysis of proton magnetic resonance spectroscopic data from plate cultures. J. Clin. Microbiol. 39:2916-2923. http://dx.doi.org/10.1128/JCM.39.8.2916-2923.2001.
293. Himmelreich U, Somorjai RL, Dolenko B, Lee OC, Daniel HM, Murray R, Mountford CE, Sorrell TC. 2003. Rapid identification of Candida species by using nuclear magnetic resonance spectroscopy and a statistical classification strategy. Appl. Environ. Microbiol. 69:4566-4574. http://dx.doi.org/10.1128/AEM.69.8.4566-4574.2003.
294. Neely LA, Audeh M, Phung NA, Min M, Suchocki A, Plourde D, Blanco M, Demas V, Skewis LR, Anagnostou T, Coleman JJ, Wellman P, Mylonakis E, Lowery TJ. 2013. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci. Transl. Med. 5:182ra154. http://dx.doi.org/10.1126 /scitranslmed.3005377.
295. Zaas AK, Aziz H, Lucas J, Perfect JR, Ginsburg GS. 2010. Blood gene expression signatures predict invasive candidiasis. Sci. Transl. Med. 2:21ra17. http://dx.doi.org/10.1126/scitranslmed.3000715.
296. Pukkila-Worley R, Ausubel FM, Mylonakis E. 2011. Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog. 7:e1002074. http://dx.doi.org/10.1371/journal.ppat.1002074.